In the framework of an increasingly strengthened alliance, Syngenta will begin to distribute the biological seed treatment fungicide developed by Rizobacter

As of this winter cereal campaign, Syngenta will include a fungicide of biological synthesis developed by Rizobacter, together with INTA, in its seed treatment products portfolio.

It is a therapeutic formulation based on the Trichoderma Harzianum (Rizoderma) fungus, which has proven effective to control all seed and soil diseases that affect germination and initial development in wheat crops. Currently, it is also registered in SENASA for soybeans and rice, and will soon be approved for winter barley and legumes, such as peas and chickpeas. Because it is a biological fungicide, it promotes new mechanisms of action seeking to reduce the risks of disease resistance and to achieve a greater persistence of control. At the same time, it offers new, more sustainable and environmentally friendly tools for the end user.

Syngenta Argentina will take the first step in commercializing this new concept of seed protection; however, its potential for expansion and growth is much higher, since it includes markets such as that of Europe, where the demand for biological inputs is increasing. As a reference, in Argentina alone, the growth rate of this technology has been greater than 120% year after year, and it has covered over one million hectares of wheat in the last three years.

With this new agreement, Syngenta and Rizobacter renew their mutual trust to continue leading the main crops seed treatment market together. By adding this new strategy for sustainable management that is highly efficient for crop protection, both companies guarantee the producer a wide range of technologies to achieve maximum emergence and high yields of their crops.